Durability of sustained virologic response in patients with chronic hepatitis C after treatment with interferon α-2b alone or in combination with ribavirin.

被引：0
|
作者：
McHutchison, JG
Davis, GL
Esteban-Mur, R
Poynard, T
Ling, MH
Garaud, JJ
Albrecht, J
机构：
[1] Scripps Clin, La Jolla, CA USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
[3] Hosp Gen Valle Hebron, Barcelona, Spain
[4] Grp Hosp Pitie Salpetriere, F-75634 Paris, France
[5] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
281
引用
收藏
页码：244A / 244A
页数：1
相关论文
共 50 条
  • [1] Virologic response in patients with chronic hepatitis C after treatment with interferon 2b alone or in combination with ribavirin.
    Futuh, ARA
    Solayman, AEM
    El Hendawy, SM
    El Hadad, SM
    Omar, MM
    Kamel, MM
    HEPATOLOGY, 2002, 36 (04) : 589A - 589A
  • [2] DURABILITY OF SUSTAINED VIROLOGIC RESPONSE IN COMBINATION THERAPY WITH INTERFERON/PEGINTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS C
    Il Lee, Jung
    Lee, Jin-Woo
    Kim, Young Soo
    Shin, Yong Woon
    Lee, Don Hoeng
    Kim, Hyung Gil
    Jeong, Seok
    Park, Hyung Joo
    Park, Hyun Shin
    Hong, Soon-Sun
    HEPATOLOGY, 2008, 48 (04) : 906A - 907A
  • [3] Sustained response in chronic hepatitis C patients after six months of interferon or interferon and ribavirin.
    Cheinquer, H
    Coelho-Borges, S
    Cheinquer, N
    Lunge, V
    Ikuta, N
    Fonseca, A
    HEPATOLOGY, 1998, 28 (04) : 477A - 477A
  • [4] Early virologic response value as predictive factor of sustained virologic response to treatment with interferon α-2b plus ribavirin in chronic hepatitis C patients with or without HIV coinfection
    Buenestado-Garcia, Juan
    Rubio-Rivas, Manuel
    Rene-Espinet, Josep Maria
    Pinol-Felis, Carmen
    Egido-Garcia, Ramon
    Rubio-Caballero, Manuel
    MEDICINA CLINICA, 2006, 127 (15): : 561 - 566
  • [5] The effect of dose reduction on sustained response in patients with chronic hepatitis C receiving interferon alfa-2B in combination with ribavirin.
    McHutchison, JG
    Poynard, T
    Harvey, J
    Garaud, JJ
    Albrecht, JK
    HEPATOLOGY, 2000, 32 (04) : 223A - 223A
  • [6] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [7] Interferon-α2b/ribavirin (REBETRON®) treatment for chronic hepatitis C -: Population pharmacokinetics and pharmacodynamics of ribavirin.
    Glue, P
    Jen, F
    Gupta, SK
    Lau, G
    HEPATOLOGY, 1999, 30 (04) : 190A - 190A
  • [8] Durability of viral response to interferon alone or in combination with oral ribavirin in patients with chronic hepatitis C.
    Davis, G
    McHutchison, J
    Poynard, T
    Esteban-Mur, R
    Albrecht, J
    Cort, S
    Ling, MH
    Garaud, JJ
    HEPATOLOGY, 1999, 30 (04) : 303A - 303A
  • [9] PEG-interferon α-2b plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon A or interferon α-2b plus ribavirin therapy.
    Sulkowski, M
    Rothstein, KD
    Stein, L
    Godofsky, E
    Shoultz, D
    Hudnall, R
    Huff, M
    Dieterich, D
    HEPATOLOGY, 2001, 34 (04) : 419A - 419A
  • [10] Delayed sustained virologic response after treatment of hepatitis C with pegylated interferon and ribavirin
    Yarze, Joseph C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S273 - S273
12345